Alastin Skincare appoints Allergan aesthetics veteran to board of directors

Alastin Skincare announced in a press release it has appointed Lynn Salo to its board of directors.

Salo has 27 years of experience with Allergan in the United States, Canada and Europe, which includes her role of vice president for sales and marketing for the Facial Aesthetics Division, according to the release. She also has managed five different business units during her time at Allergan, including ophthalmology, neurosciences, urology, plastic surgery and facial aesthetics, the release reported.

Salo’s experience includes launching Allergan products including Botox, Voluma and Lumigan, according to the release.

“Lynn's appointment furthers our commitment to scientific innovation, business integrity and our customer-centric model,” Diane S. Goosetree, president and CEO of Alastin Skincare, stated in the release. “She is an accomplished executive who was instrumental in the growth and continued success of Allergan's aesthetic business. Her reputation and relationships in this field are unsurpassed.”

Alastin develops and markets clinically-tested skin care products, according to the release.

Reference: www.alastin.com